Comparing the current results to its competitors, Retractable Technologies Inc reported Revenue decrease in the 2 quarter 2026 year on year by -27.21 %, despite the revenue increase by the most of its competitors of 7.8 %, recorded in the same quarter.
Retractable Technologies Inc's Comment on Competition and Industry Peers
The company operates in the U.S. healthcare market, competing primarily with Becton, Dickinson and Company (BD) and Embecta Corp., a diabetes management spin-off from BD. Both competitors have larger market shares and greater resources. The company focuses its competition on healthcare worker and patient safety, product performance, and quality.
Publicly Traded Peers of Retractable Technologies Inc
Sharps Technology Inc Share Performance
-52.68%
This Year
Sharps Technology Inc
Profile
Sharps Technology Inc operates as a technology solutions provider, offering a range of products and services to businesses in various industries. Their business model is focused on developing and delivering innovative technological solutions tailored to meet their clients' specific needs and requirements. By leveraging their expertise, they aim to help businesses enhance efficiency, productivity, and overall performance through the implementation of cutting-edge technological solutions.
Staar Surgical Co employs a business model focused on developing, manufacturing, and distributing implantable lenses used for the treatment of refractive errors such as myopia and astigmatism. The company primarily sells its products to eye surgeons and ophthalmologists globally, generating revenue through product sales and royalties from licensing agreements. By constantly innovating and expanding its product portfolio, Staar Surgical Co aims to improve vision outcomes for patients and maintain a competitive position in the ophthalmic market.
Surmodics Inc operates on a business model centered around the development and commercialization of innovative medical device and pharmaceutical technologies. The company focuses on creating surface modification technologies, such as drug delivery coatings, that enhance the performance and functionality of medical devices and improve therapeutic outcomes. Surmodics Inc collaborates with industry partners to license or directly manufacture and sell their proprietary products in various medical fields.
Procept Biorobotics Corporation follows a business model focused on developing medical robotics solutions for urology procedures. Their flagship product, the AquaBeam System, utilizes waterjet technology to perform minimally invasive surgeries for patients with benign prostatic hyperplasia. The company aims to improve patient outcomes and reduce healthcare costs by providing an innovative and efficient alternative to traditional surgical methods.
Penumbra Inc operates on a business model that focuses on the development and manufacturing of innovative medical devices. They aim to provide cutting-edge technologies and solutions to improve patient outcomes in various medical fields. The company primarily generates revenue through the sales of their medical devices to healthcare professionals and institutions worldwide.
Sources:
Retractable Technologies Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Retractable Technologies Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
